Protocols for Brain Cancer
| HIC 0612002148 Joachim Baehring M.D. A Phase II/III Randomized Study of CDX-110 with Radiation and Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme |
| HIC 0805003858 Gary Kupfer ANBL0531-Response- and Biology-Based Therapy for Intermediate-risk Neuroblastoma |
| HIC 0810004300 Jonathan Knisely M.D. RTOG 0614: A Randomized, Phase III, Double-Blind, Placebo- Controlled Trial of Memantine for Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy |
| HIC 0904005078 Jonathan Knisely M.D. RTOG0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation & Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation & Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma |
| HIC 0709003072 Joachim Baehring M.D. A Phase III Randomized, Parallel Group, Multicenter Study in Recurrent Glioblastoma Patients to Compare the Efficacy of CEDARINIB(AZD2171, RECENTIN) Monotherapy and the Combination ofAZD2171 with Lomustine to the Efficacy of Lomustine Alone |